Avaleht › Haavandiline koliit › Massachusetts
Haavandiline koliit kliinilised uuringud osariigis Massachusetts
16 uuringut haiguse Haavandiline koliit jaoks otsivad osalejaid osariigis Massachusetts.
Linnad osariigis Massachusetts
Ametlik uuringutekst (inglise keeles)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Lucida Clinical Trials /ID# 282000, New Bedford
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Framingham, Framingham
- Lucida Clinical Trials LLC, New Bedford
VärbamineFaas 4
Vanused 18–80 · Kõik sood · Uuendatud 30. sept 2026 · NCT06581328A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 003, Boston
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 29. sept 2026 · NCT07012395A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Boston Children's Hospital, Boston
- University of Massachusetts Chan Medical School, Worcester
VärbamineFaas 2/3
Vanused 2–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Lucida Clinical Trials, New Bedford
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. sept 2026 · NCT03816345LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Brigham and Women's Hospital, Boston
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 22. sept 2026 · NCT07186101A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Boston Children's Hospital, Boston
- Massachusetts General Hospital, Waltham
VärbamineFaas 3
Vanused 2–19 · Kõik sood · Uuendatud 22. sept 2026 · NCT04844606An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Tufts Medical Center - Site Number: 8400126, Boston
- UMass Memorial Medical Center - Site Number: 8400121, Worcester
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 20. aug 2026 · NCT07184996Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Brigham and Women's Hospital, Boston
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 5. aug 2026 · NCT07237516Treatment of UC With Novel Therapeutics
- Brigham and Women's Hospital, Chestnut Hill
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 21. juuli 2026 · NCT06420375A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Boston Children's Hospital, Boston
VärbamineFaas 2
Vanused 12–17 · Kõik sood · Uuendatud 8. juuli 2026 · NCT05287126Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- Massachusetts General Hospital, Boston
Värbamine
Vanused 18–85 · Kõik sood · Uuendatud 8. jaan 2026 · NCT05987852Study of Novel Therapeutics for Acute Remedy of Colitis
- Brigham and Women's Hospital, Chestnut Hill
- Brigham and Women's Hospital, Chestnut Hill
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 20. okt 2025 · NCT06420492High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
- Boston Children's Hospital, Boston
VärbamineVaatlusuuring
Vanused 5–25 · Kõik sood · Uuendatud 3. märts 2025 · NCT04331639Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
- Massachusetts General Hospital, Boston
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 14 ja vanemad · Kõik sood · Uuendatud 20. dets 2024 · NCT06655415Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.